Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2940094 in Alcohol Dependence
NCT01798303Phase 2Completed
- Sponsor
- BlackThorn Therapeutics
- Start
- Jul 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LY2940094 in alcohol dependence, sponsored by BlackThorn Therapeutics. Started Jul 2013; status: completed.
02
Drugs
LY2940094
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01798303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798303.